Ectopic pregnancy in a breast cancer patient receiving trastuzumab

Reproductive Toxicology

Volumn 25, Issue 2, 2008, Pages 286-288

  Berveiller, Paul ^a   Mir, Olivier ^a   Sauvanet, Eric ^a   Antoine, Eric Charles ^b   Goldwasser, François ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Hartmann Clinic   (France)

Author keywords

Breast cancer; Ectopic pregnancy; HER 2; Implantation; Pregnancy; Trastuzumab

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; FLUOROURACIL; MONOCLONAL ANTIBODY; TRASTUZUMAB;

ABORTION; ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CASE REPORT; COMBINATION CHEMOTHERAPY; DRUG SAFETY; ECHOGRAPHY; ECTOPIC PREGNANCY; FEMALE; FETUS DEVELOPMENT; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MULTIPLE CYCLE TREATMENT; NIDATION; ONCOGENE NEU; PHYSICAL EXAMINATION; PREGNANCY; PROGNOSIS; TREATMENT DURATION; VAGINA BLEEDING;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY, ECTOPIC;

EID: 39749154156     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2007.11.004     Document Type: Article

References (15)

1. Strobelt N., Locatelli A., Ratti M., and Ghidini A. Cervico-isthmic pregnancy: a case report, critical reappraisal of the diagnostic criteria, and reassessment of the outcome. Acta Obstet Gynecol Scand 80 (2001) 586-588
2. Brown N., Deb K., Paria B.C., Das S.K., and Reese J. Embryo-uterine interactions via the neuregulin family of growth factors during implantation in the mouse. Biol Reprod 71 (2004) 2003-2011
3. Lim H., Dey S.K., and Das S.K. Differential expression of the erbB2 gene in the periimplantation mouse uterus: potential mediator of signaling by epidermal growth factor-like growth factors. Endocrinology 138 (1997) 1328-1337
4. Beuzeboc P. Indications for Herceptin in breast cancer treatment. Gynecol Obstet Fertil 32 (2004) 164-172
5. Loibl S., vonMinckwitz G., Gwyn K., Ellis P., Blohmer J.U., Schlegelberger B., et al. Breast carcinoma during pregnancy. International recommendations from an expert meeting. Cancer 106 (2006) 237-246
6. Shrim A., Garcia-Bournissen F., Maxwell C., Farine D., and Koren G. Favorable pregnancy outcome following Trastuzumab (Herceptin((R)) use during pregnancy. Case report and updated literature review. Reprod Toxicol 23 (2007) 611-613
7. Watson W.J. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstet Gynecol 105 (2005) 642-643
8. Fanale M.A., Uyei A.R., Theriault R.L., Adam K., and Thompson R.A. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin Breast Cancer 6 (2005) 354-356
9. Waterston A.M., and Graham J. Effect of adjuvant trastuzumab on pregnancy. J Clin Oncol 24 (2006) 321-322
10. Bader A.A., Schlembach D., Tamussino K.F., Pristauz G., and Petru E. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol 8 (2007) 79-81
11. Mir O., Berveiller P., and Pons G. Trastuzumab - mechanism of action and use. N Engl J Med 357 (2007) 1664-1665
12. Yoshimura S., Masuzaki H., Miura K., et al. Effect of epidermal growth factor on lung growth in experimental fetal pulmonary hypoplasia. Early Hum Dev 57 (2000) 61-69
13. Challier P., and Briere N. Mitogenic effects of EGF/TGF alpha and immunolocalization of cognate receptors in human fetal kidneys. Biofactors 7 (1998) 323-335
14. Ni J., Ni Y., Wang X., Xu W., Wang Y., and Xiong S. Application of a gene vaccine targeting HER-2/neu in immunocontraception. DNA Cell Biol 23 (2004) 807-814
15. David M.P., Bergman A., and Delighdish L. Cervico-isthmic pregnancy carried to term. Obstet Gynecol 56 (1980) 247-252